News

Scientific news
<p>Marco Milán and Héctor Herranz in the Developmental and Growth Control Lab at the IRB Barcelona</p>
5 May 2008

The finding made in the fruit fly may provide clues to address problems such as the proliferation of malignant cells and tumour growth in humans

Institutional news
<p>Màrius Rubiralta</p>
15 Apr 2008

The IRB Barcelona principal investigator has been appointed to the post by the new Minister of Science and Innovation, Cristina Garmendia.

Institutional news
11 Apr 2008

Experts in systems biology, molecular pharmacology and bioengineering convene in Barcelona, invited by IRB Barcelona and the BBVA Foundation.

Institutional news
<p>Agreement signature</p>
7 Apr 2008

Today the “Fundación Científica de la Asociación Española Contra el Cáncer” (AECC)(Scientific Foundation of the Spanish Association Against Cancer) and the Institute for Research in Biomedicine (IRB Barcelona) have signed an agreement through which the Foundation will fund the cancer research project entitled, “Estudio de los mecanismos moleculares de la metástasis del cáncer de mama a pulmón: función y potencial terapéutico de genes supresores de metástasis” (Study of the molecular mechanisms of metastasis of breast cancer to the lung: therapeutic function and potential of metastasis suppressor genes). The signing of this agreement was done in IRB Barcelona...

Scientific news
<p>Gomis and Massagué at the IRB Barcelona</p>
4 Apr 2008

The study, headed by Joan Massagué in New York, has involved researchers at IRB Barcelona and Hospital Clínic-IDIBAPS.

Scientific news
<p>The infective action is produced by the prion PrP106-126</p>
31 Mar 2008

Researchers at IRB Barcelona have demonstrated that the decrease in Dab1 protein expression caused by the infective action of prions also reduces the production of β-amyloid, a risk factor of Alzheimer’s disease.

Institutional news
10 Mar 2008

Epilepsy, cancer, diabetes and depression are just some examples of the severe diseases associated with mutations in these proteins.

Institutional news
<p>Antibiotic by Omnia</p>
5 Mar 2008

The biotech company Omnia Molecular shared by IRB Barcelona, opens its new facilities in the Barcelona Science Park.

Institutional news
19 Feb 2008

Otorgado por la revista Actualidad Económica y el diario Expansión

Scientific news
<p>Bacteria <i>M. Penetrans</i> has an extension in its enzime MetRS (in yellow) which makes it different from the rest of organisms. Stuying this enzime, the scientists discovered a new mechanism for genetic code translation</p>
14 Feb 2008

Researchers study the evolution of life by examining the translation of the genetic codes of several organisms, in order to discover differences between bacteria and humans that allow the design of new antibiotics